mechanism of action of glp 1 receptor agonist Frontiers GLP−1 Receptor Agonist Mechanisms GLP−1RAs
Description
This in-depth analysis explores the potential link between chronic hyperglycemia, a hallmark of diabetes, and diabetic peripheral neuropathy (DPN), a devastating complication characterized by nerve damage
Trelagliptin is approved in Japan since 2015
As the body of literature on this topic expands, more refined clinical guidance for the use of GLP-1RAs is expected to emerge
Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis
Cell, 153(6), 11941217
doi: 10.2174/1381612033454775 [DOI] [PubMed] [Google Scholar] 26
